Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market, Global Outlook and Forecast 2022-2028
Exosomes are a type of vesicles (Extracellular Vesicles, EVs) secreted by cells to the outside of the cell, with a size of 30-150nm, a double-layer membrane structure and a saucer-like shape, and rich contents (including nucleic acids, proteins and lipids, etc.), involved in the transfer of molecules between cells.
As an emerging technology, it has many problems, including accurately encoding and delivering targeted therapeutics, not to mention issues surrounding intellectual property and large-scale manufacturing. For diagnostic applications, products from Exosome Diagnostics are available; for therapeutic applications, although there are three listed companies focusing on exosomes - Capricor, Puretech and Reneuron, none of the company's products have actually been used in clinical practice.
This report contains market size and forecasts of Msenchymal Stem Cell and Exosome Diagnostics and Therapies in Global, including the following market information:
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Msenchymal Stem Cell and Exosome Diagnostics and Therapies include Tianjin Angsai Cell Genetic Engineering Co. Ltd, Qingdao Aoke Biological Development Co. Ltd, Beijing SH biotechnology Co. Ltd, Beijing Beilai Biotechnology Co. Ltd, Shanghai Aisar Biotechnology Co. Ltd, Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd, Beijing Han's United Biotechnology Co. Ltd, Bosheng Excellence Biotechnology (Beijing) Co. Ltd and Cellular Biomedicine Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Msenchymal Stem Cell and Exosome Diagnostics and Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Segment Percentages, by Type, 2021 (%)
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Segment Percentages, by Application, 2021 (%)
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Msenchymal Stem Cell and Exosome Diagnostics and Therapies revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Msenchymal Stem Cell and Exosome Diagnostics and Therapies revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
As an emerging technology, it has many problems, including accurately encoding and delivering targeted therapeutics, not to mention issues surrounding intellectual property and large-scale manufacturing. For diagnostic applications, products from Exosome Diagnostics are available; for therapeutic applications, although there are three listed companies focusing on exosomes - Capricor, Puretech and Reneuron, none of the company's products have actually been used in clinical practice.
This report contains market size and forecasts of Msenchymal Stem Cell and Exosome Diagnostics and Therapies in Global, including the following market information:
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Msenchymal Stem Cell and Exosome Diagnostics and Therapies include Tianjin Angsai Cell Genetic Engineering Co. Ltd, Qingdao Aoke Biological Development Co. Ltd, Beijing SH biotechnology Co. Ltd, Beijing Beilai Biotechnology Co. Ltd, Shanghai Aisar Biotechnology Co. Ltd, Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd, Beijing Han's United Biotechnology Co. Ltd, Bosheng Excellence Biotechnology (Beijing) Co. Ltd and Cellular Biomedicine Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Msenchymal Stem Cell and Exosome Diagnostics and Therapies companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Segment Percentages, by Type, 2021 (%)
- Type I
- Type II
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Segment Percentages, by Application, 2021 (%)
- Diagnostics
- Therapies
- Skincare
Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Msenchymal Stem Cell and Exosome Diagnostics and Therapies revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Msenchymal Stem Cell and Exosome Diagnostics and Therapies revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Tianjin Angsai Cell Genetic Engineering Co. Ltd
- Qingdao Aoke Biological Development Co. Ltd
- Beijing SH biotechnology Co. Ltd
- Beijing Beilai Biotechnology Co. Ltd
- Shanghai Aisar Biotechnology Co. Ltd
- Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd
- Beijing Han's United Biotechnology Co. Ltd
- Bosheng Excellence Biotechnology (Beijing) Co. Ltd
- Cellular Biomedicine Group
- Guangzhou Celera Stem Cell Technology Co. Ltd.
- Stem Med Pte Ltd
- CryoCord Sdn Bhd
- Cytopeutics Sdn Bhd
- Stempeutics Research Pvt Ltd
- Asian Institute of Gastroenterology
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL MSENCHYMAL STEM CELL AND EXOSOME DIAGNOSTICS AND THERAPIES OVERALL MARKET SIZE
2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size: 2021 VS 2028
2.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players in Global Market
3.2 Top Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies Ranked by Revenue
3.3 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue by Companies
3.4 Top 3 and Top 5 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies in Global Market, by Revenue in 2021
3.5 Global Companies Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players in Global Market
3.6.1 List of Global Tier 1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies
3.6.2 List of Global Tier 2 and Tier 3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Markets, 2021 & 2028
4.1.2 Type I
4.1.3 Type II
4.2 By Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue & Forecasts
4.2.1 By Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2017-2022
4.2.2 By Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2023-2028
4.2.3 By Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2021 & 2028
5.1.2 Diagnostics
5.1.3 Therapies
5.1.4 Skincare
5.2 By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue & Forecasts
5.2.1 By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2017-2022
5.2.2 By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2023-2028
5.2.3 By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2021 & 2028
6.2 By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue & Forecasts
6.2.1 By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2017-2022
6.2.2 By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2023-2028
6.2.3 By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2017-2028
6.3.2 US Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.3.3 Canada Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.3.4 Mexico Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2017-2028
6.4.2 Germany Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.4.3 France Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.4.4 U.K. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.4.5 Italy Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.4.6 Russia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.4.7 Nordic Countries Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.4.8 Benelux Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2017-2028
6.5.2 China Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.5.3 Japan Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.5.4 South Korea Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.5.5 Southeast Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.5.6 India Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2017-2028
6.6.2 Brazil Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.6.3 Argentina Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2017-2028
6.7.2 Turkey Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.7.3 Israel Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.7.4 Saudi Arabia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.7.5 UAE Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Tianjin Angsai Cell Genetic Engineering Co. Ltd
7.1.1 Tianjin Angsai Cell Genetic Engineering Co. Ltd Corporate Summary
7.1.2 Tianjin Angsai Cell Genetic Engineering Co. Ltd Business Overview
7.1.3 Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.1.4 Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.1.5 Tianjin Angsai Cell Genetic Engineering Co. Ltd Key News
7.2 Qingdao Aoke Biological Development Co. Ltd
7.2.1 Qingdao Aoke Biological Development Co. Ltd Corporate Summary
7.2.2 Qingdao Aoke Biological Development Co. Ltd Business Overview
7.2.3 Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.2.4 Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.2.5 Qingdao Aoke Biological Development Co. Ltd Key News
7.3 Beijing SH biotechnology Co. Ltd
7.3.1 Beijing SH biotechnology Co. Ltd Corporate Summary
7.3.2 Beijing SH biotechnology Co. Ltd Business Overview
7.3.3 Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.3.4 Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.3.5 Beijing SH biotechnology Co. Ltd Key News
7.4 Beijing Beilai Biotechnology Co. Ltd
7.4.1 Beijing Beilai Biotechnology Co. Ltd Corporate Summary
7.4.2 Beijing Beilai Biotechnology Co. Ltd Business Overview
7.4.3 Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.4.4 Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.4.5 Beijing Beilai Biotechnology Co. Ltd Key News
7.5 Shanghai Aisar Biotechnology Co. Ltd
7.5.1 Shanghai Aisar Biotechnology Co. Ltd Corporate Summary
7.5.2 Shanghai Aisar Biotechnology Co. Ltd Business Overview
7.5.3 Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.5.4 Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.5.5 Shanghai Aisar Biotechnology Co. Ltd Key News
7.6 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd
7.6.1 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Corporate Summary
7.6.2 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Business Overview
7.6.3 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.6.4 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.6.5 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Key News
7.7 Beijing Han's United Biotechnology Co. Ltd
7.7.1 Beijing Han's United Biotechnology Co. Ltd Corporate Summary
7.7.2 Beijing Han's United Biotechnology Co. Ltd Business Overview
7.7.3 Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.7.4 Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.7.5 Beijing Han's United Biotechnology Co. Ltd Key News
7.8 Bosheng Excellence Biotechnology (Beijing) Co. Ltd
7.8.1 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Corporate Summary
7.8.2 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Business Overview
7.8.3 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.8.4 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.8.5 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Key News
7.9 Cellular Biomedicine Group
7.9.1 Cellular Biomedicine Group Corporate Summary
7.9.2 Cellular Biomedicine Group Business Overview
7.9.3 Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.9.4 Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.9.5 Cellular Biomedicine Group Key News
7.10 Guangzhou Celera Stem Cell Technology Co. Ltd.
7.10.1 Guangzhou Celera Stem Cell Technology Co. Ltd. Corporate Summary
7.10.2 Guangzhou Celera Stem Cell Technology Co. Ltd. Business Overview
7.10.3 Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.10.4 Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.10.5 Guangzhou Celera Stem Cell Technology Co. Ltd. Key News
7.11 Stem Med Pte Ltd
7.11.1 Stem Med Pte Ltd Corporate Summary
7.11.2 Stem Med Pte Ltd Business Overview
7.11.3 Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.11.4 Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.11.5 Stem Med Pte Ltd Key News
7.12 CryoCord Sdn Bhd
7.12.1 CryoCord Sdn Bhd Corporate Summary
7.12.2 CryoCord Sdn Bhd Business Overview
7.12.3 CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.12.4 CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.12.5 CryoCord Sdn Bhd Key News
7.13 Cytopeutics Sdn Bhd
7.13.1 Cytopeutics Sdn Bhd Corporate Summary
7.13.2 Cytopeutics Sdn Bhd Business Overview
7.13.3 Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.13.4 Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.13.5 Cytopeutics Sdn Bhd Key News
7.14 Stempeutics Research Pvt Ltd
7.14.1 Stempeutics Research Pvt Ltd Corporate Summary
7.14.2 Stempeutics Research Pvt Ltd Business Overview
7.14.3 Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.14.4 Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.14.5 Stempeutics Research Pvt Ltd Key News
7.15 Asian Institute of Gastroenterology
7.15.1 Asian Institute of Gastroenterology Corporate Summary
7.15.2 Asian Institute of Gastroenterology Business Overview
7.15.3 Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.15.4 Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.15.5 Asian Institute of Gastroenterology Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL MSENCHYMAL STEM CELL AND EXOSOME DIAGNOSTICS AND THERAPIES OVERALL MARKET SIZE
2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size: 2021 VS 2028
2.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players in Global Market
3.2 Top Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies Ranked by Revenue
3.3 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue by Companies
3.4 Top 3 and Top 5 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies in Global Market, by Revenue in 2021
3.5 Global Companies Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Type
3.6 Tier 1, Tier 2 and Tier 3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players in Global Market
3.6.1 List of Global Tier 1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies
3.6.2 List of Global Tier 2 and Tier 3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Markets, 2021 & 2028
4.1.2 Type I
4.1.3 Type II
4.2 By Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue & Forecasts
4.2.1 By Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2017-2022
4.2.2 By Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2023-2028
4.2.3 By Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2021 & 2028
5.1.2 Diagnostics
5.1.3 Therapies
5.1.4 Skincare
5.2 By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue & Forecasts
5.2.1 By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2017-2022
5.2.2 By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2023-2028
5.2.3 By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2021 & 2028
6.2 By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue & Forecasts
6.2.1 By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2017-2022
6.2.2 By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2023-2028
6.2.3 By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2017-2028
6.3.2 US Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.3.3 Canada Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.3.4 Mexico Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2017-2028
6.4.2 Germany Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.4.3 France Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.4.4 U.K. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.4.5 Italy Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.4.6 Russia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.4.7 Nordic Countries Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.4.8 Benelux Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2017-2028
6.5.2 China Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.5.3 Japan Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.5.4 South Korea Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.5.5 Southeast Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.5.6 India Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2017-2028
6.6.2 Brazil Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.6.3 Argentina Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2017-2028
6.7.2 Turkey Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.7.3 Israel Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.7.4 Saudi Arabia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
6.7.5 UAE Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Tianjin Angsai Cell Genetic Engineering Co. Ltd
7.1.1 Tianjin Angsai Cell Genetic Engineering Co. Ltd Corporate Summary
7.1.2 Tianjin Angsai Cell Genetic Engineering Co. Ltd Business Overview
7.1.3 Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.1.4 Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.1.5 Tianjin Angsai Cell Genetic Engineering Co. Ltd Key News
7.2 Qingdao Aoke Biological Development Co. Ltd
7.2.1 Qingdao Aoke Biological Development Co. Ltd Corporate Summary
7.2.2 Qingdao Aoke Biological Development Co. Ltd Business Overview
7.2.3 Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.2.4 Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.2.5 Qingdao Aoke Biological Development Co. Ltd Key News
7.3 Beijing SH biotechnology Co. Ltd
7.3.1 Beijing SH biotechnology Co. Ltd Corporate Summary
7.3.2 Beijing SH biotechnology Co. Ltd Business Overview
7.3.3 Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.3.4 Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.3.5 Beijing SH biotechnology Co. Ltd Key News
7.4 Beijing Beilai Biotechnology Co. Ltd
7.4.1 Beijing Beilai Biotechnology Co. Ltd Corporate Summary
7.4.2 Beijing Beilai Biotechnology Co. Ltd Business Overview
7.4.3 Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.4.4 Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.4.5 Beijing Beilai Biotechnology Co. Ltd Key News
7.5 Shanghai Aisar Biotechnology Co. Ltd
7.5.1 Shanghai Aisar Biotechnology Co. Ltd Corporate Summary
7.5.2 Shanghai Aisar Biotechnology Co. Ltd Business Overview
7.5.3 Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.5.4 Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.5.5 Shanghai Aisar Biotechnology Co. Ltd Key News
7.6 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd
7.6.1 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Corporate Summary
7.6.2 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Business Overview
7.6.3 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.6.4 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.6.5 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Key News
7.7 Beijing Han's United Biotechnology Co. Ltd
7.7.1 Beijing Han's United Biotechnology Co. Ltd Corporate Summary
7.7.2 Beijing Han's United Biotechnology Co. Ltd Business Overview
7.7.3 Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.7.4 Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.7.5 Beijing Han's United Biotechnology Co. Ltd Key News
7.8 Bosheng Excellence Biotechnology (Beijing) Co. Ltd
7.8.1 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Corporate Summary
7.8.2 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Business Overview
7.8.3 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.8.4 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.8.5 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Key News
7.9 Cellular Biomedicine Group
7.9.1 Cellular Biomedicine Group Corporate Summary
7.9.2 Cellular Biomedicine Group Business Overview
7.9.3 Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.9.4 Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.9.5 Cellular Biomedicine Group Key News
7.10 Guangzhou Celera Stem Cell Technology Co. Ltd.
7.10.1 Guangzhou Celera Stem Cell Technology Co. Ltd. Corporate Summary
7.10.2 Guangzhou Celera Stem Cell Technology Co. Ltd. Business Overview
7.10.3 Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.10.4 Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.10.5 Guangzhou Celera Stem Cell Technology Co. Ltd. Key News
7.11 Stem Med Pte Ltd
7.11.1 Stem Med Pte Ltd Corporate Summary
7.11.2 Stem Med Pte Ltd Business Overview
7.11.3 Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.11.4 Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.11.5 Stem Med Pte Ltd Key News
7.12 CryoCord Sdn Bhd
7.12.1 CryoCord Sdn Bhd Corporate Summary
7.12.2 CryoCord Sdn Bhd Business Overview
7.12.3 CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.12.4 CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.12.5 CryoCord Sdn Bhd Key News
7.13 Cytopeutics Sdn Bhd
7.13.1 Cytopeutics Sdn Bhd Corporate Summary
7.13.2 Cytopeutics Sdn Bhd Business Overview
7.13.3 Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.13.4 Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.13.5 Cytopeutics Sdn Bhd Key News
7.14 Stempeutics Research Pvt Ltd
7.14.1 Stempeutics Research Pvt Ltd Corporate Summary
7.14.2 Stempeutics Research Pvt Ltd Business Overview
7.14.3 Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.14.4 Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.14.5 Stempeutics Research Pvt Ltd Key News
7.15 Asian Institute of Gastroenterology
7.15.1 Asian Institute of Gastroenterology Corporate Summary
7.15.2 Asian Institute of Gastroenterology Business Overview
7.15.3 Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Major Product Offerings
7.15.4 Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global Market (2017-2022)
7.15.5 Asian Institute of Gastroenterology Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Opportunities & Trends in Global Market
Table 2. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Drivers in Global Market
Table 3. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Restraints in Global Market
Table 4. Key Players of Msenchymal Stem Cell and Exosome Diagnostics and Therapies in Global Market
Table 5. Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Share by Companies, 2017-2022
Table 8. Global Companies Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Type
Table 9. List of Global Tier 1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2023-2028
Table 30. Tianjin Angsai Cell Genetic Engineering Co. Ltd Corporate Summary
Table 31. Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 32. Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 33. Qingdao Aoke Biological Development Co. Ltd Corporate Summary
Table 34. Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 35. Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 36. Beijing SH biotechnology Co. Ltd Corporate Summary
Table 37. Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 38. Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 39. Beijing Beilai Biotechnology Co. Ltd Corporate Summary
Table 40. Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 41. Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 42. Shanghai Aisar Biotechnology Co. Ltd Corporate Summary
Table 43. Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 44. Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 45. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Corporate Summary
Table 46. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 47. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 48. Beijing Han's United Biotechnology Co. Ltd Corporate Summary
Table 49. Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 50. Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 51. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Corporate Summary
Table 52. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 53. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 54. Cellular Biomedicine Group Corporate Summary
Table 55. Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 56. Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 57. Guangzhou Celera Stem Cell Technology Co. Ltd. Corporate Summary
Table 58. Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 59. Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 60. Stem Med Pte Ltd Corporate Summary
Table 61. Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 62. Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 63. CryoCord Sdn Bhd Corporate Summary
Table 64. CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 65. CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 66. Cytopeutics Sdn Bhd Corporate Summary
Table 67. Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 68. Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 69. Stempeutics Research Pvt Ltd Corporate Summary
Table 70. Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 71. Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 72. Asian Institute of Gastroenterology Corporate Summary
Table 73. Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 74. Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 1. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Opportunities & Trends in Global Market
Table 2. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Drivers in Global Market
Table 3. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Restraints in Global Market
Table 4. Key Players of Msenchymal Stem Cell and Exosome Diagnostics and Therapies in Global Market
Table 5. Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Share by Companies, 2017-2022
Table 8. Global Companies Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Type
Table 9. List of Global Tier 1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2023-2028
Table 30. Tianjin Angsai Cell Genetic Engineering Co. Ltd Corporate Summary
Table 31. Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 32. Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 33. Qingdao Aoke Biological Development Co. Ltd Corporate Summary
Table 34. Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 35. Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 36. Beijing SH biotechnology Co. Ltd Corporate Summary
Table 37. Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 38. Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 39. Beijing Beilai Biotechnology Co. Ltd Corporate Summary
Table 40. Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 41. Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 42. Shanghai Aisar Biotechnology Co. Ltd Corporate Summary
Table 43. Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 44. Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 45. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Corporate Summary
Table 46. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 47. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 48. Beijing Han's United Biotechnology Co. Ltd Corporate Summary
Table 49. Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 50. Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 51. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Corporate Summary
Table 52. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 53. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 54. Cellular Biomedicine Group Corporate Summary
Table 55. Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 56. Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 57. Guangzhou Celera Stem Cell Technology Co. Ltd. Corporate Summary
Table 58. Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 59. Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 60. Stem Med Pte Ltd Corporate Summary
Table 61. Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 62. Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 63. CryoCord Sdn Bhd Corporate Summary
Table 64. CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 65. CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 66. Cytopeutics Sdn Bhd Corporate Summary
Table 67. Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 68. Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 69. Stempeutics Research Pvt Ltd Corporate Summary
Table 70. Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 71. Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
Table 72. Asian Institute of Gastroenterology Corporate Summary
Table 73. Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Offerings
Table 74. Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Segment by Type in 2021
Figure 2. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Segment by Application in 2021
Figure 3. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in 2021
Figure 8. By Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
Figure 9. By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
Figure 10. By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
Figure 11. By Country - North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
Figure 12. US Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
Figure 16. Germany Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 17. France Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
Figure 24. China Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 28. India Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
Figure 30. Brazil Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
Figure 33. Turkey Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 37. Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Segment by Type in 2021
Figure 2. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Segment by Application in 2021
Figure 3. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in 2021
Figure 8. By Type - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
Figure 9. By Application - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
Figure 10. By Region - Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
Figure 11. By Country - North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
Figure 12. US Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
Figure 16. Germany Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 17. France Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
Figure 24. China Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 28. India Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
Figure 30. Brazil Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share, 2017-2028
Figure 33. Turkey Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue, (US$, Mn), 2017-2028
Figure 37. Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Beijing Han's United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
